Publications by authors named "Miriam Shpigelman"

Article Synopsis
  • The study aimed to assess if a slower, flexible titration of semaglutide could enhance adherence and minimize gastrointestinal side effects in patients with type 2 diabetes compared to the standard titration method.
  • A total of 104 patients were divided into two groups: one followed the standard dosage increase schedule, while the other had a more gradual dosage increase with the option to pause if gastrointestinal issues arose.
  • Results showed that the flexible group had significantly fewer withdrawals due to adverse events and reported lower levels of nausea and fatigue, while effectiveness in managing diabetes (measured by HbA1c and BMI) remained similar between both groups.
View Article and Find Full Text PDF

Objectives: The objective of this study is to report the prevalence, clinical characteristics and healthcare utilisation of patients with type 2 diabetes (T2DM) and previously undiagnosed cognitive impairment who were identified as having a low Montreal Cognitive Assessment (MoCA) score.

Design: A population-based cohort study comparing clinical characteristics, medications, outpatient and inpatient care of patients with a MoCA score <19 to MoCA >26 using descriptive statistics, linear regression and multivariate logistic regression.

Setting: Electronic medical records of a large health maintenance organisation in Israel.

View Article and Find Full Text PDF

Purpose: The study examined the role of diabetes nurse practitioners (DiNPs) and their contribution to the quality of care of individuals with diabetes during the COVID-19 pandemic. Specifically, we examined the benefits and barriers of using telemedicine for managing diabetes.

Design: A descriptive qualitative research using content analysis of interviews.

View Article and Find Full Text PDF

Introduction: People with diabetes mellitus are at increased risk of developing a more severe disease or death when contracting coronavirus disease 2019 (COVID-19 ) but the effect of pre-COVID-19 infection glycemic control on disease outcomes is still unclear. In a previous study that we published from Leumit Health Services (LHS) including 183 patients with diabetes, pre-COVID-19 infection HbA1c>9% was associated with the need for hospitalization during the disease. In the current study we present the clinical characteristics of patients who died from COVID-19 in LHS and demonstrate a significant link to pre-infection HbA1c.

View Article and Find Full Text PDF

Aims: In 2011 the central district of Leumit Health Services (LHS) (a health maintenance organization in Israel) implemented a chronic care program to improve diabetes care in general practice: MESSAGE program (Motivation, Education, Skills and Supervision to Achieve better diabetes care in General practice Environment), included training phase and ongoing time allocation for diabetes care.

Methods: A population-based retrospective analysis of LHS Electronic Medical Records of all patients with diabetes in LHS between 1 June 2015 and 31 May 2018. Data was processed according to the definitions of the Israeli national program for quality indicators in community healthcare.

View Article and Find Full Text PDF

Aim: Poor outcomes of coronavirus disease 2019 (COVID-19) have been linked to diabetes, but its relation to pre-infection glycaemic control is still unclear.

Materials And Methods: To address this question, we report here the association between pre-infection Haemoglobin A1c (HbA1c) levels and COVID-19 severity as assessed by need for hospitalization in a cohort of 2068 patients with diabetes tested for COVID-19 in Leumit Health Services (LHSs), Israel, between 1 February and 30 April 2020. Using the LHS-integrated electronic medical records system, we were able to collect a large amount of clinical information including age, sex, socio-economic status, weight, height, body mass index, HbA1c, prior diagnosis of ischaemic heart disease, depression/anxiety, schizophrenia, dementia, hypertension, cerebrovascular accident, congestive heart failure, smoking, and chronic lung disease.

View Article and Find Full Text PDF